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Abstract 
Background 
Executive dysfunction is common in substance use disorder (SUD) populations and 
hinders treatment. We previously found that 50% of residents in SUD therapeutic 
communities had been hospitalized for head injuries; this was a significant 
determinant of cognitive impairment. The current study aimed to establish whether 
cognitive remediation improves executive functions (EFs) and self-regulation in an 
ecologically valid sample of female residents attending SUD therapeutic community 
treatment, including those with past head injuries and psychiatric comorbidities. 
Methods 
Controlled sequential groups design with residents (N = 33, all female) receiving 
treatment as usual (TAU). The intervention group (n = 16) completed four weeks of 
cognitive remediation (CR) and the control, TAU only (n = 17). Outcome measures 
assessed pre- and post-intervention included both performance- and inventory-based 
measures of EFs, and self-reported self-regulation and quality of life. 
Results 
CR relative to TAU significantly improved performance-based assessment of 
inhibition (Color-Word Interference Test; F = 4.29, p = 0.047), inventory-based 
assessment of EFs (Behavior Rating Inventory of Executive Function - Adult Version: 
Global Executive Composite; F = 6.38, p = 0.017), impulsivity (Barratt Impulsiveness 
Scale; F = 4.61, p = 0.040), self-control (Brief Self-Control Scale; F = 5.53, p = 
0.026) and quality of life (Quality of Life Enjoyment and Satisfaction Questionnaire - 
Short Form; F = 7.68, p = 0.010). 
Conclusions 
Findings suggest that CR improves EFs in a heterogeneous sample of female residents 
in therapeutic community SUD treatment. Future research may explore the possibility 
of tailoring CR interventions for various SUD subgroups. 
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1. Introduction 
 Self-regulation is a protective factor in ameliorating many social and mental 
health problems and is understood as the capacity “to make plans, choose from 
alternatives, control impulses, inhibit unwanted thoughts and regulate social behavior” 
(Heatherton & Wagner, 2011, p. 132). Individuals in residential rehabilitation 
treatment for substance use disorders (SUDs) must possess some capacity for self-
regulation in order to meaningfully engage in treatment and ultimately change their 
behavior. This is particularly true of Therapeutic Community treatment 
(Vanderplasschen et al., 2013), which entails significant social participation and 
shared responsibility for activities of daily life. 
 Cognitive deficits are one of the four biggest risk factors for dropout from 
SUD treatment (Brorson et al., 2013), and executive function (EF) impairment is 
commonly observed in individuals experiencing SUDs (Fernández-Serrano et al., 
2010; Hester et al., 2010). Diverse definitions of EFs exist (Friedman & Miyake, 
2016) but they are broadly understood as “those capacities that enable a person to 
engage successfully in independent, purposive, self-directed, and self-serving 
behavior” (Lezak et al., 2012, p. 37). An influential threefold model of EFs includes 
‘working memory’, ‘inhibition’, and ‘shifting’ (Miyake et al., 2000). Working 
memory refers to the capacity to monitor and alter information held in mind 
temporarily, inhibition involves overriding an unwanted distraction to maintain task-
focus, and shifting pertains to flexibly switching attention between tasks or mental 
sets (Hofmann et al., 2012). These basic EFs are intricately linked to and may 
subserve effective self-regulation (Hofmann et al., 2012). 
 Individuals in residential treatment for SUDs often have psychiatric and 
medical comorbidities, including history of head injury. For example, we previously 
found that 67.2% of residents in SUD Therapeutic Community treatment (70.3% 
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male) had sustained one or more head injuries, while 50% required hospitalisation 
following a head injury (Marceau et al., 2016). History of head injury was a 
significant determinant of cognitive impairment and was associated with higher levels 
of psychological distress. Psychiatric comorbidities are also frequently observed in 
SUD populations and add further complexity to the process of addiction recovery 
(Baingana et al., 2015). Personality disorders are particularly prevalent (e.g. Pennay et 
al., 2011) and are not only associated with global neurocognitive and specific EF 
deficits, (Fertuck et al., 2006; Ruocco & Carcone, 2016; Unoka & Richman, 2016), 
but also with dropout from SUD treatment (Brorson et al., 2013). 
 Given the high rates of head injury and psychiatric comorbidities in SUD 
populations, and the positive relationship of these variables with cognitive impairment, 
the application of evidence-based neuropsychological interventions designed for use 
in both brain injury (usually referred to as cognitive rehabilitation) and mental health 
(usually referred to as cognitive remediation) populations might be expected to result 
in reductions of cognitive impairment, and potentially lead to better SUD treatment 
outcomes. It has been recommended that these interventions be adapted for use in 
SUD treatment populations (Bates et al., 2013a) and there have been a number of 
attempts at this to date (e.g., Alfonso et al., 2011; Bickel et al., 2011; Houben et al., 
2011; Valls-Serrano et al., 2016a). 
Neuropsychological interventions for SUD populations have tended to adopt 
either a drill and practice (e.g., Houben et al., 2011) or strategy-based (e.g., Valls-
Serrano et al., 2016a) approach. To our knowledge, there are no published studies 
incorporating a combined approach that utilises both domains. The cognitive 
remediation literature within psychiatry has suggested that whilst drill and practice 
approaches (e.g., computerized cognitive training) may lead to greater gains on 
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cognitive test scores, strategy-based training (e.g., instruction in specific strategy use) 
leads to greater functional outcomes for individuals with schizophrenia (Paquin et al., 
2014; Wykes et al., 2011). Combining approaches in an SUD population may result in 
greater gains across a range of measures. This study aimed to determine the 
effectiveness of a cognitive remediation intervention that incorporated both drill and 
practice and strategy-based training for a treatment seeking SUD population, inclusive 
of those with psychiatric and head injury comorbidities. 
 Assessment of EFs may be performance- (i.e., assessing performance on 
working memory, inhibition, and shifting tasks) or inventory-based (i.e., based on 
self-reports of executive functioning). Whilst performance-based measures of EFs are 
sensitive to brain impairment that implicates the frontal lobes (Jurado & Roselli, 
2007), some may demonstrate limited ecological validity and may not capture 
problems with everyday functioning as well as inventory-based measures (Isquith et 
al., 2013). Inventory- and performance-based measures of EFs are minimally 
correlated and may assess distinct components of EFs that contribute independently to 
clinical problems (Toplak et al., 2013). For example, to determine the relative 
sensitivities of performance- and inventory-based EFs measures in an SUD treatment 
population, Hagen and colleagues (2016) showed that inventory-based assessment 
using the Behavior Rating Inventory of Executive Function – Adult Version (BRIEF-
A; Roth et al., 2005) better distinguished polysubstance users from controls and was 
more strongly associated with real-world social adjustment outcomes compared to 
performance-based measures, which included the Iowa Gambling Task (Bechara et al., 
1994), the Trail-Making Test (Strauss et al., 2006), and the Stroop test (Golden, 1978). 
In light of these findings and to provide a more comprehensive assessment of EFs, the 
current study included both performance- and inventory-based measures. 
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 The current study aimed to examine the effectiveness of cognitive remediation 
vs. treatment-as-usual (TAU) in: (1) improving performance- and inventory-based 
measures of EFs and (2) improving self-report measures of self-regulation. Quality of 
life was included as a secondary clinical outcome measure, as it plays an important 
role in sustained remission from SUDs (Laudet et al., 2009). We hypothesized that 
cognitive remediation would be effective in improving EFs, self-regulation, and 
quality of life. 
 
2. Methods 
2.1. Participants 
 Fifty participants were recruited from a women’s residential treatment facility 
in Sydney run by We Help Ourselves (WHOs) – a large provider of residential SUD 
rehabilitation in Australia, utilising the Therapeutic Community model of treatment. 
Inclusion criteria for the study were: (i) diagnosis of substance abuse/dependence, 
based on DSM-IV-TR criteria, assessed using the Mini-International Neuropsychiatric 
Interview (MINI-Plus; Sheehan et al., 1998), (ii) a minimum abstinence period of 7 
days (with confirmation of detoxification a prerequisite of entry to treatment), (iii) 
absence of any neurological, infectious, or other disease affecting the central nervous 
system (e.g., epileptic seizures, stroke, brain tumour, meningitis, encephalitis, 
multiple sclerosis, HIV positive), and (iv) English as native language. A condition of 
staying at the residential facility is that participants remain abstinent from substances 
of abuse and this is monitored through routine urinalysis (random resident checks 
occurring several times per week) and 24-hour observation from experienced staff and 
co-residents. 
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2.2. Diagnostic and clinical assessment 
 Diagnostic and clinical assessment at baseline included the following: 
Psychiatric comorbidities (DSM-IV-TR) were assessed using the MINI-Plus and 
Standardised Assessment of Personality – Abbreviated Scale (Moran et al., 2003), as 
shown to be appropriate for SUD populations (Gonzalez, 2014; Hesse & Moran, 
2010; Hesse et al., 2008). Questions were adapted from the Addiction Severity Index 
– Fifth Edition (ASI; McLellan et al., 1992) to assess lifetime substance use history. 
Additionally, a brief semi-structured interview was used to assess history of head 
injury. The Test of Premorbid Functioning (TOPF; Pearson Assessment, 2009) was 
used to estimate overall level of intellect. 
 
2.3. Outcome measures 
2.3.1. Executive functions – performance-based 
2.3.1.1. Working memory: Working Memory Index (WMI; Wechsler Adult Intelligence 
Scale, fourth edition: WAIS-IV; Wechsler, 2008). The WMI of the WAIS-IV assesses 
components of working memory and is comprised of 2 subtests, which were 
administered according to standard instructions. The digit span subtest requires 
participants to recall various sequences of numbers (forward, backward, and in 
sequence) and the arithmetic subtest involves participants solving numerical problems 
within 30 seconds, after they have been read aloud by the examiner. The subtest 
scores were summed to yield a total score, which was then scaled to provide an index 
score, as per standardized scoring instructions. 
2.3.1.2. Inhibition: Color-Word Interference Test (Delis-Kaplan Executive Function 
System: D-KEFS; Delis et al., 2001). This subtest of the D-KEFS assesses response 
inhibition and provides an auxiliary measure of shifting. Participants are instructed to 
 8
read the items presented in each of four conditions as quickly and accurately as 
possible. Performance is measured in time (seconds). The first condition presents 
patches of colours and requires participants to name the colours. The second condition 
presents the words “red”, “blue”, and “green” and requires participants to read the 
words. The third condition presents words printed in incongruent colours and requires 
the participant to ignore the word and say the colour. The fourth condition presents 
words printed in incongruent colours and requires the participant to switch between 
two rules: (a) ignore the word and say the colour; and (b) ignore the colour and say 
the word. Outcome variables were contrast scaled scores of inhibition (condition 3 
scaled score minus condition 1 scaled score) and inhibition/shifting (condition 4 
scaled score minus condition 1 scaled score). 
2.3.1.3. Shifting: Trail-Making Test (TMT; Strauss et al., 2006). This test provides a 
measure of shifting, with Part A assessing simple psychomotor ability and Part B 
assessing psychomotor ability and shifting. In part A, participants connect 25 
numbered circles in ascending order. In part B, 13 numbers and 12 letters have to be 
alternately connected in their numerical and alphabetical order. Participants are 
notified of any errors immediately and must correct them without assistance. The 
outcome variable was the difference in time (seconds) to complete part B versus part 
A (time B minus time A), which specifically reflects shifting. 
2.3.2. Executive functions – inventory-based 
Behavior Rating Inventory of Executive Function – Adult Version (BRIEF-A; Roth et 
al., 2005). The BRIEF-A is a 75-item self-report questionnaire consisting of nine 
subscales. Participants are instructed to answer each question by selecting “never”, 
“sometimes”, or “often”, in relation to whether they have had problems with any of 
the listed behaviors in the past month. Example items include: “I have trouble getting 
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ready for the day”; “I have trouble coming up with ideas for what to do with my free 
time”. The Global Executive Composite (GEC) provides an overall summary score. 
The Behavioral Regulation Index (BRI) includes the subscales Inhibit; Shift; 
Emotional Control; Self-Monitor. The Metacognition Index (MI) includes subscales 
Initiate; Working Memory; Plan/Organize; Task Monitor; Organisation of Materials. 
Elevated scores indicate executive dysfunction. Scores on the GEC, BRI, and MI 
subscales were used as outcome variables in the analyses. 
2.3.3. Self-regulation 
2.3.3.1. Barratt Impulsiveness Scale – Version 11 (BIS-11; Patton et al., 1995). The 
BIS-11 is a 30-item self-report questionnaire that assesses trait and behavioral aspects 
of the construct of impulsivity. There are six first-order factors: Attention, Cognitive 
Instability, Motor, Perseverance, Self-Control, and Cognitive Complexity. These first-
order factor scores were summed to yield a total score, which was used as the 
outcome variable. 
2.3.3.2. Brief Self-Control Scale (BSCS; Tangney et al., 2004). The BSCS is a 13-item 
self-report questionnaire that assesses individual differences in the construct of self-
control. The outcome variable was total score. 
2.3.3.3. Difficulties in Emotion Regulation Scale (DERS; Gratz & Roemer, 2004). The 
DERS is a 41-item self-report questionnaire that assesses clinically relevant 
difficulties in emotion regulation. There are six subscales (Nonacceptance of 
Emotional Responses, Difficulties Engaging in Goal-Directed Behavior, Impulse 
Control Difficulties, Lack of Emotional Awareness, Limited Access to Emotion 
Regulation Strategies, and Lack of Emotional Clarity) contributing to a total score, 
which was used as the outcome variable. 
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2.3.3.4. Penn Alcohol Craving Scale (PACS; Flannery et al., 1999). The PACS is a 5-
item self-report questionnaire that assesses level of cravings for alcohol and other 
drugs. Participants were asked to respond to all items in relation to their primary 
substance of misuse. The outcome variable was total score. 
2.3.4. Quality of Life Enjoyment and Satisfaction Questionnaire – short form (Q-LES-
Q-SF; Endicott et al., 1993). The Q-LES-Q-SF is a 16-item self-report questionnaire 
that assesses quality of life across areas of daily functioning. Total score was used as 
the outcome variable. 
 
2.4. Design and procedures 
 The study employed a controlled sequential groups design and was a 
naturalistic study, capturing a snapshot of residents in treatment at the time of 
recruitment. This design was chosen due to resource constraints and logistic difficulty 
of having the small sample of residents in treatment at any one time being allocated to 
differing treatment regimes. All residents in the treatment facility were invited to 
participate in the study and the response rate was 96%. Those who met inclusion 
criteria and provided consent took part in either: (a) a cognitive remediation (CR; n = 
23) group program or (b) treatment as usual (TAU; n = 27). The CR group were 
recruited first followed by the TAU group, allowing sufficient time for a new cohort 
of residents to become available. Unexpectedly, the CR group had spent more time in 
treatment prior to baseline assessment (Mdn = 67 days) than the TAU group (Mdn = 
25 days). 
 Both groups engaged in the usual Therapeutic Community model of treatment 
(Vanderplasschen et al., 2013). In addition to this, the CR group attended a total of 12 
x 2-hour group sessions across 4 weeks (3 sessions per week held on Mondays, 
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Wednesdays, and Fridays). All participants in the CR group attended these sessions at 
the same time, with all sessions facilitated by the second author (JB) and co-
facilitated by the first author (EM). The first hour of each session was dedicated to 
strategy training, which included traditional instructional pedagogical approaches, 
modelling, exercises to demonstrate concepts, and role-plays. The second hour 
included group computerized cognitive training using the Lumosity application 
(Lumosity, 2016) on iPads. Although Lumosity has not previously been used in SUD 
populations, it has been utilized across a broad range of other clinical populations 
(e.g., multiple sclerosis (Charvet et al., 2015), childhood cancer-related brain injury 
(Kesler et al., 2011) and mild cognitive impairment (Dannhauser et al., 2014)) and 
was chosen for its web-based platform and ease of access. Participants played specific 
games during which they were instructed to use and practice certain strategies that 
linked to the strategy-based learning in the previous hour. They were asked to share 
other strategies they may have found useful during the cognitive exercises and this 
was discussed and sometimes integrated with the learning material by the facilitators. 
The amount of time spent training on each game was held constant, rather than the 
number of trials of each game. This allowed participants to progress through the 
exercises at their own pace. The CR intervention was developed with a strong 
emphasis on the training of EFs and self-regulation in view of the finding that EFs are 
particularly impaired in an SUD treatment population. The intervention incorporated 
elements from well researched CR interventions designed for an acquired brain injury 
(ABI) population, including self-alert training (O’Connell et al., 2008; Robertson et 
al., 1995), goal management training (Levine et al., 2011), time pressure management 
(Fasotti et al., 2000), and multifaceted treatment of executive dysfunction (Spikman et 
al., 2010). Other relevant evidence-based interventions originally designed for a non-
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ABI population were also incorporated, such as mental contrasting and 
implementation intentions (Duckworth et al., 2011). Barkley’s (2001; 2012) 
evolutionary model of EFs was used to structure a large component of the program. 
The modules covered the following topics: levels of brain functioning, attention, 
learning and memory, executive functions, self-awareness, inhibition, visual and 
verbal working memory, emotion regulation, decision-making and problem-solving. 
The facilitators followed a manual (available on request) to ensure treatment 
consistency. 
 The CR group completed baseline assessments in the week prior to the 
commencement of the intervention and post-intervention assessments in the week 
following its completion. Similarly, the TAU group completed baseline assessments 
followed by a period of approximately 4 weeks and were reassessed during the 
subsequent week. There was a 5-day difference between groups in the interval 
between baseline and post-intervention assessments (CR: Mdn = 34 days; TAU: Mdn 
= 29 days). The final sample size, accounting for treatment dropout, was 33: n = 16 
(CR group) and n = 17 (TAU group). During the study period, the rates of unplanned 
discharges from the residential program did not significantly differ between groups 
(CR = 30%, TAU = 37%, X2 = 0.24, p = 0.62) and are comparable to those observed 
in SUD Therapeutic Community treatment (Darke et al., 2012). 
 
2.5. Statistical methods 
 All statistical analyses were performed using IBM Statistical Package for the 
Social Sciences (SPSS version 21; IBM Corp, 2012). Standardized residuals were 
assessed to detect possible outliers (values greater than ± 3). Two outliers were found 
in the Inhibition condition of the Color-Word Interference Test and one was found in 
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the Trail Making Test B-A. With exclusion of these outliers from analyses, the pattern 
of results did not change and therefore outliers were retained. One missing value was 
detected in the TAU group (PACS) and three were detected in the CR group (BSCS; 
DERS; Q-LES-Q-SF). 
 Socio-demographic characteristics of the CR vs. TAU groups were compared 
using Student’s t-test and Mann-Whitney U tests as a nonparametric alternative. Chi-
square and Fisher’s exact tests were used to compare percentage variables. 
 Despite significant differences in treatment duration and days from baseline to 
post-intervention between groups, these variables were not included as covariates in 
subsequent analyses. This is based on the recommendations of Kraemer (2015) that 
covariates should be selected a priori and be as few in number as possible, with a 
subsequent option of examining moderators of treatment response separately (see 
Discussion). However, any potential influence of these variables was probed in a 
series of separate preliminary exploratory analyses using ANCOVA to compare all 
outcome variables between groups, including the covariates of baseline score, 
treatment duration, and days from baseline to post-intervention. 
 Analysis of covariance (ANCOVA; with baseline score as covariate) was the 
preferred method of primary analysis for all outcome variables (Egbewale et al., 
2014; Kraemer, 2015; Overall & Ashby, 1991), which were analysed separately. 
 ANCOVA could not be applied to two analyses (Inhibition/Shifting vs. Colour 
Naming and Q-LES-Q-SF) due to non-normal distributions, as determined by 
Shapiro-Wilk tests of within-group and overall model standardized residuals. 
Subsequently, Quade’s (1967) rank ANCOVA was conducted as a nonparametric 
ANCOVA alternative (Olejnik & Algina, 1984). In a further two analyses (TMT and 
DERS), ANCOVA was deemed to be inappropriate due to violation of statistical 
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assumptions. As a result, two 2 (Time: Pre- vs. Post-intervention) x 2 (Treatment: CR 
vs. TAU) mixed-design analyses of variance (ANOVAs) were conducted with a 
logarithmic data transformation for one variable (TMT) whereas the other (DERS) 
was not able to be transformed and is reported despite violation of the assumption of 
homogeneity of variances, as assessed by Levene's test of homogeneity of variance (p 
< .05). 
 
3. Results 
 Table 1 presents socio-demographic characteristics and substance use and 
head injury history for CR vs. TAU groups. There were no significant differences in 
age (CR: Mdn = 32.5 years, range 22–56; TAU: Mdn = 33 years, range 19–53), 
education (CR: Mdn = 12 years, range 7–15; TAU: Mdn = 12 years, range 7–20), 
intelligence, employment, marital status, or history of losing 
consciousness/concussion or hospitalisation after a head injury. Additionally, primary 
substance of misuse did not significantly differ between groups, with significant 
heterogeneity observed. The descriptive data regarding substance use history 
presented in Table 1 suggests that participants used a variety of substances over many 
years, with particularly high rates of polysubstance use. Treatment duration was 
significantly longer (p = .003) for participants in the CR group (Mdn = 67 days, range 
16–160) compared to the TAU group (Mdn = 25 days, range 2–82). Additionally, 
there was a 5-day difference between groups in the interval between baseline and 
post-intervention assessments (p = .005) (CR: Mdn = 34 days, range 33–36; TAU: 
Mdn = 29 days, range 26–36). 
 
Table 1 
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Baseline socio-demographic, substance use and head injury characteristics of residents of a female-
only substance use therapeutic community 
Characteristic    Cognitive Remediation  Treatment As Usual p 
      (n = 16)   (n = 17) 
Age (M, SD)a       33.6 (10.1)    32.9 (7.6) .85 
Education (M, SD)a      11.3 (2.4)    11.6 (2.6) .82 
Test of Premorbid Functioning (M, SD)    96.0 (11.7)    99.1 (12.9) .48 
Unemployed (%)b      81.2     82.4                1.00 
Marital status (% single)b      75.0     82.4  .69 
Primary substance of misuse (%)c        .20 
Methamphetamine     50.0     29.4 
Alcohol       18.8     35.3   
       Amphetamines      12.5       0 
 Heroin         6.2     11.8   
       Cannabis         0     17.6   
 Sedatives      12.5       5.9 
Years of regular use 
    Alcohol (any use; M, Mdn, SD; n)    12.9 (13.5, 9.0; 12)     9.5 (6.5, 7.0; 16) 
    Alcohol (to intoxication; M, Mdn, SD; n)       10.0 (8.0, 7.2; 11)     8.0 (5.0, 7.0; 16) 
    Heroin (M, Mdn, SD; n)       16.0 (n = 1)      9.7 (8.0, 8.6; 5) 
    Methadone (M, Mdn, SD; n)          8.0 (n = 1)      8.3 (8.3, 11.0; 2) 
   Other opiates/analgesics (M, Mdn, SD; n)      11.5 (12.0, 4.3; 3)     7.2 (6.0, 5.7; 5) 
    Sedatives/hypnotics/tranquilizers (M, Mdn, SD; n) 10.6 (12.0, 4.4; 5)     6.3 (3.5, 6.0; 8) 
    Cocaine (M, Mdn, SD; n)           7.0 (4.0, 7.9; 3)     7.0 (8.5, 4.2; 4) 
    Amphetamines (M, Mdn, SD; n)           7.8 (8.0, 5.6; 14)      9.2 (10.5, 6.1; 12) 
    Cannabis (M, Mdn, SD; n)       11.2 (10.0, 7.7; 13)   10.5 (12.5, 6.6; 13) 
    Hallucinogens (M, Mdn, SD; n)          5.2 (3.0, 6.1; 5)     8.0 (8.0, 5.7; 2) 
    More than one substance per day (M, Mdn, SD; n)    9.5 (9.5, 4.9; 12)   10.6 (10.0, 6.7; 15) 
Lost consciousness/concussion after head injury (%)c   50.0     58.8  .61 
Hospitalized after head injury (%)c     25.0     47.1  .19 
a Mann-Whitney U test. b Fisher’s exact test. c Chi-square test. 
 
 Psychiatric comorbidity data for the CR vs. TAU groups are displayed in 
Table 2. No significant differences between groups were found for the proportions 
meeting criteria for current or past Axis I diagnoses (other than SUDs), personality 
disorders, or the full range of other psychiatric comorbidities. 
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Table 2 
Psychiatric comorbidities of residents of a female-only substance use therapeutic community 
Psychiatric Comorbidity   Cognitive Remediation  Treatment As Usual p 
      (n = 16)   (n = 17) 
Current Axis I psychiatric diagnosisa (%)    56.2     76.5  .22 
Past Axis I psychiatric diagnosisa (%)    68.8     64.7  .81 
Personality disorder screen (met criteria)a (%)   50.0     41.2  .61 
Major depressive episodea         .81 
   Never (lifetime)      50.0    35.3 
   Major depressive episode (past 2 weeks)    18.7    11.8 
   Substance-induced mood disorder (past 2 weeks)     0      5.9 
   Mood disorder due to medical condition      0      5.9 
      (past 2 weeks) 
   Past major depressive episode     25.0    35.3  
   Past mood disorder due to medical condition     6.2      5.9 
Dysthymiaa             .40 
   Never (lifetime)      56.2    76.5 
   Dysthymia (past 2 years)     25.0    17.6 
   Past dysthymia       18.8      5.9 
Manic episodea             .54 
   Never (lifetime)      87.5    70.6  
   Current manic episode        0      0 
   Past manic episode        0    11.8 
   Past hypomanic episode        6.2      5.9 
   Past substance-induced hypomanic episode     6.2      5.9 
   Past hypomanic episode due to medical condition     0      5.9 
Panic disordera             .63 
   Never (lifetime)      62.5    70.6 
   Panic disorder (past month)       6.2      0 
   Substance-induced anxiety disorder with 
      panic attacks (past month)       0      5.9 
   Anxiety disorder with panic attacks due to 
      a medical condition (past month)      6.2      5.9 
   Panic disorder (lifetime)      18.8      5.9 
   Panic disorder symptoms (lifetime)      6.2    11.8 
Agoraphobiaa           .29 
   Never (lifetime)      43.8    70.6    
   Current agoraphobia      31.2    17.6 
   Agoraphobia (lifetime)      25.0    11.8 
Social phobiab (past month)          1.0 
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   No        81.2    82.4 
   Yes        18.8    17.6 
Specific phobiab (past month)           .23 
   No        87.5               100 
   Yes        12.5      0 
Obsessive compulsive disorder 
   Not current (past month)    100               100   
Posttraumatic stress disorderb           .66 
   Never (lifetime)      81.2    88.2 
   Posttraumatic stress disorder (past month)    18.8    11.8 
Psychotic disorderb (lifetime)          1.0 
   Never        75.0    76.5 
   Substance-induced psychotic disorder    25.0    23.5 
Anorexia nervosa           
   Not current (past 3 months)   100                   100 
Bulimia nervosab (past 3 months)        .49 
   No      100       88.2 
   Yes          0    11.8 
Generalized anxiety disordera (past 6 months)      .16 
   No        68.8    58.8   
   Yes         25.0    17.6 
   Substance-induced generalised 
      anxiety disorder        0    23.5 
   Generalised anxiety disorder due to 
      medical condition        6.2      0 
Antisocial personality disorderb (lifetime)       .71 
   No       75.0    64.7 
   Yes       25.0    35.3 
Somatization disorder 
   Never (lifetime)      100               100 
Hypochondriasisb             1.0 
   Never (lifetime)    100    94.1  
   Hypochondriasis (past 6 months)       0      5.9 
Pain disorder 
   Not current        100               100 
Adult attention deficit/hyperactivity disorderb (lifetime)     1.0 
   No        81.2    76.5 
   Yes        18.8    23.5  
Probable premenstrual dysphoric disorderb (past year)       .40 
   No        75.0    88.2 
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   Yes        25.0    11.8 
a Chi-square test. b Fisher’s exact test. 
  
 The exploratory ANCOVA analyses of all outcome variables including 
baseline score, treatment duration, and days from baseline to post-intervention as 
covariates, found treatment duration to be significant in only one analysis (BIS-11, p 
= .045) and the interval between baseline and post-intervention in only one other 
(BSCS, p  = .036). These variables conferred only a small effect, with BIS-11 
decreasing by .07 units for every one-day increase in treatment duration, and BSCS 
increasing by .06 units for every one-day increase in assessment interval. 
 Primary ANCOVA and mixed-design ANOVA results are displayed in Table 
3. With baseline scores included as covariates, post-intervention scores in the CR 
group relative to the TAU group were significantly higher for the Color-Word 
Interference Test (Condition Three: Inhibition vs. Colour Naming) and significantly 
lower for GEC and MI of the BRIEF-A, with a trend also for BRI; a pattern of results 
indicating that the CR vs. TAU group displayed improvements in executive functions. 
The CR group also differed from the TAU group on the self-regulation measures, 
with lower BIS-11 and higher BSCS scores, as well as higher Q-LES-Q-SF scores, 
and a trend towards lower PACS scores. These results indicate that the CR group 
relative to the TAU group displayed reduced impulsivity, higher self-control, and 
higher quality of life, as well as a trend towards reduced cravings. 
 ANCOVA results indicated no significant differences between groups for 
WMI and Inhibition/Shifting vs. Color Naming, and mixed-design ANOVA results 
indicated no significant Time x Treatment interactions for TMT and the DERS.
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Table 3 
Post-intervention effects of cognitive remediation vs. treatment as usual on executive functions, self-regulation and quality of life in residents of a female-only substance use 
therapeutic community 
Dependent measures    Cognitive Remediation (CR)  Treatment As Usual (TAU)  F p Partial 
      (n = 16)     (n = 17)       η2    
      Baseline  Post-intervention  Baseline  Post-intervention    
      M (SD)  Adjusted M (SD)  M (SD)  Adjusted  M (SD)  
Executive functions      
 WMI     91.88 (10.61) 96.97 (6.08)  93.53 (13.01) 95.85 (6.08)  0.28 0.60 0.009  
 Inhibition vs. Colour Naming    9.44 (3.01) 11.44 (1.73)  10.47 (2.00) 10.18 (1.73)  4.29 0.047* 0.125 
 Inhibition/Shifting vs. Colour Naminga   9.31 (3.14) 11.44 (2.19)  10.41 (2.27) 10.77 (2.05)  1.41 0.25 0.043 
 †TMT (B-A; time s)b,c   38.47 (17.63) 35.27 (20.79)  31.50 (9.27) 21.13 (7.78)  1.80 0.19 0.058 
BRIEF-A 
    †Global Executive Composite   59.44 (11.19) 53.07 (6.94)  67.59 (12.47) 59.35 (6.93)  6.38 0.017* 0.175     
    †Behavioral Regulation Index   60.63 (12.40) 55.28 (7.74)  67.59 (10.24) 60.32 (7.73)  3.34 0.08 0.100 
    †Metacognition Index    57.31 (10.36) 51.46 (6.50)  66.41 (13.78) 57.04 (6.49)  5.69 0.024* 0.160  
Self-regulation 
 †BIS-11     75.44 (12.15) 70.57 (7.39)  77.76 (14.08) 76.11 (7.39)  4.61 0.04* 0.133 
 BSCSd       2.81 (0.90)   2.90 (0.42)    2.13 (0.87)   2.55 (0.40)  5.53 0.026* 0.160 
 †DERSb,d,e    94.93 (33.15) 88.60 (31.10)  94.47 (16.37) 92.47 (14.02)  0.44 0.51 0.014 
 †PACSf       9.31 (8.47)   7.84 (5.54)  11.56 (6.01) 11.48 (5.54)  3.41 0.08 0.105 
Quality of life 
 Q-LES-Q-SFa,d      0.62 (0.12)     0.71 (0.06)    0.55 (0.18)   0.61 (0.16)  7.68 0.01** 0.204  
* p ≤ .05 ** p ≤ .01 
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ANCOVA analyses: Post-intervention adjusted means determined using baseline values as covariates. 
Partial η2 effect size interpretation guidelines (Cohen, 1988): 0.01 = small; 0.06 = medium; 0.14 = large. 
† Lower scores reflect better performance. 
a Quade’s nonparametric rank analysis of covariance: post-intervention unadjusted M (SD), Quade’s F statistic. 
b 2 x 2 mixed-design analysis of variance: post-intervention unadjusted M (SD), F-Interaction. 
c Logarithmic data transformation (n = 31 as 2 cases unable to be transformed). 
d CR group n = 15. 
e Data could not be transformed. 
f TAU group n = 16.
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4. Discussion 
 This study aimed to test the effectiveness of cognitive remediation to improve 
executive functions, self-regulation and quality of life in female residents of an SUD 
therapeutic community. It was based on a theoretical framework positing that basic 
EFs underpin effective self-regulation (i.e., the capacity for effective goal-directed 
behavior in everyday life; Hofmann et al., 2012). Results indicated that the group 
receiving the CR intervention improved performance on an inhibition task, facets of 
self-regulation (i.e., impulsivity and self-control) and quality of life post-intervention 
relative to the TAU group. CR also improved self-reported EFs (i.e., GEC and MI of 
the BRIEF-A, with a trend towards BRI) compared to TAU. Additionally, there was a 
trend towards reduced cravings in the CR vs. TAU group. These results provide 
significant new evidence for the potential utility of neuropsychological interventions 
in SUD treatment contexts. Importantly, the current study suggests that CR may be a 
viable intervention in SUD treatment settings where high rates of comorbidities such 
as past head injuries and psychiatric diagnoses are common. 
 Inhibition is one of the EFs recognized as making a significant contribution to 
the development and maintenance of SUD (Jentsch & Pennington, 2014). The core 
inhibitory deficits contributing to SUD are increased tendencies to approach 
substances and/or the inability to suppress this approach-behavior, which manifest at 
different levels of analysis and have been assessed via behavioral task-specific and 
trait self-report methods (Gullo et al., 2014). There is ongoing debate over the use of 
self-report vs. behavioral laboratory task assessment methodology, with strengths and 
weakness of each method noted (Cyders & Coskunpinar, 2011). The current study 
utilized task-specific assessment of inhibition and inventory-based measurement of 
impulsivity (i.e., BIS-11), with improvements in task-performance and reduced levels 
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of trait impulsivity reported in the CR group. Although these findings may seem to 
converge, it has been noted that self-report measures vs. behavioral laboratory tasks 
may assess divergent components of the construct (Cyders & Coskunpinar, 2011). 
 Self-control is inversely related to trait impulsivity and refers to the capacity 
to overcome unwanted urges to achieve goal-directed behavior (Hofmann et al., 2012). 
Self-control plays an important role in SUD (Volkow et al., 2013) and interacts 
dynamically with cravings in contributing to problematic substance use (Grasman et 
al., 2016). Decreased self-control is associated with cumulative stress and this 
relationship is moderated by self-reported, but not behavioral, impulsivity (Hamilton 
et al., 2014). The CR group in the current study reported increased self-control, which 
may have played a role in the marginal decrease also reported for cravings. 
Interventions that bolster self-control in SUD populations, such as CR, may help to 
shield against the deleterious effects of cravings (Fatseas et al., 2015) and stress 
(Sinha et al., 2011) in relapse to substance use. 
 Unlike previous cognitive remediation interventions that focused on one 
component of cognition (e.g., working memory training in Houben et al., 2011), the 
current study incorporated training exercises that involved a range of cognitive skills 
(e.g., working memory, selective attention, divided attention, planning, inhibition, and 
flexibility). As such, the reduced total training time on some components may partly 
explain the absence of effects on some EF domains. It is possible that the domains 
that showed gains had more time dedicated to them during the strategy and drill 
practice components of the program. 
 The CR group also demonstrated improvements in EFs as measured by the 
BRIEF-A. Specifically, these improvements were observed in the overall summary 
score (GEC) and one of the index scores (MI), with a trend towards improvement in 
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the other index score (BRI). Given the minimal correlation between inventory- and 
performance-based measures of EFs and likelihood that such methods of assessment 
may be capturing distinct components of EFs (Toplak et al., 2013), the improvements 
observed across both types of measures in the current study may indicate a robust 
change in EF. Further research, however, is needed to tease apart the complex 
relationship between various components of EFs and self-regulation. This endeavour 
could involve diverse methodologies and several levels of analysis (e.g., self-report, 
laboratory tasks, neuropsychological assessment, neuroimaging techniques, clinical 
outcomes). 
 Quality of life spans broad areas of psychological wellbeing, physical health, 
level of independence, and social connectedness, and has been defined as “an 
individual's perception of their position in life in the context of the culture and value 
systems in which they live and in relation to their goals, expectations, standards and 
concerns” (Feelemyer et al., 2014, p. 251). Findings from the current study showed 
that CR impacted positively upon quality of life. This is a promising preliminary 
finding as quality of life is an important predictor of sustained remission from SUD 
(Laudet et al., 2009). 
 A recent study found that cognitive training improved EFs (i.e., working 
memory and reflection-impulsivity/decision-making) in polysubstance users in 
Therapeutic Community treatment (Valls-Serrano et al., 2016a). Importantly, that 
study was the first to also demonstrate improved self-regulation performance in an 
ecologically valid task of goal-directed behavior, the Multiple Errands Test − 
contextualized version (Shallice & Burgess, 1991; Valls-Serrano et al., 2016b). The 
study excluded participants with psychiatric comorbidities and those with a history of 
head injury to capture efficacy of cognitive training. In a previous study we 
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demonstrated that 50% of residents in residential treatment for SUD had been 
hospitalized after sustaining a head injury and this was a significant determinant of 
cognitive impairment (Marceau et al., 2016). Psychiatric comorbidities are common 
(Baingana et al., 2015), with Borderline Personality Disorder diagnosed in up to 65% 
of individuals with SUDs (Pennay et al., 2011). Similarly, the current study found that 
over 50% of the overall sample met criteria for a current Axis I diagnosis, while over 
40% had a positive screen for personality disorder. Over 50% of the sample had lost 
consciousness or been concussed after a head injury and over 30% had been 
hospitalized after a head injury. The current study extends the findings of Valls-
Serrano and colleagues (2016a) to a research context high in ecological validity by 
including participants with psychiatric or head injury comorbidities. In the present 
study, there were improvements on conventional neuropsychological tests (e.g., 
inhibition task), whereas that was not the case in the Valls-Serrano (2016a) study. 
This may be due to the inclusion of computerized cognitive training and/or because 
the present sample were more impaired by virtue of greater comorbidities. These 
preliminary results suggest that cognitive remediation may be a viable option to 
improve EFs and self-regulation for SUD populations, including those with 
psychiatric and/or head injury comorbidities. 
 A strength of the current study is that it shows significant promise for the use 
of CR interventions as adjunct treatments for SUD. To the best of our knowledge, this 
is the first study to inclusively demonstrate feasibility and effectiveness of 
neuropsychological intervention for female residents that engage in SUD therapeutic 
communities, without exclusion of those with psychiatric and head injury 
comorbidities. Certain limitations, however, must be noted. The sample size of the 
current study was small and it used a controlled sequential groups design. Related to 
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the constraints of this design, the significant difference in length of treatment and 
assessment interval between groups was not ideal. This is particularly relevant to the 
observed improvements in impulsivity and self-control, as these improvements were, 
to some degree, respectively related to variance in treatment length and assessment 
interval observed between groups. Future studies should investigate the benefit of CR 
in groups matched on interval between assessments and treatment duration, 
accounting for the heterogeneity of treatment length occurring across SUD 
populations in residential facilities. Specifically, studies should further examine the 
role of treatment and/or abstinence length in relation to the neurocognitive and self-
regulation improvements that may occur as a result of cognitive training. It is also 
important to note that while statistical tests revealed no significant differences in 
socio-demographic, psychiatric, head injury, and primary substance of misuse 
characteristics between CR vs. TAU groups, there were apparent differences in 
history of substance use (i.e., years of regular use across substances) which were not 
compared statistically due to insufficient subgroup sample sizes. Taken together, and 
particularly in light of the small sample size of this study, these limitations raise the 
possibility of significant between-group variability due to the range of potential 
confounding factors (e.g., treatment duration and hence abstinence length, assessment 
interval, primary substance of misuse, and substance use history). For these reasons, it 
is imperative that future studies aim to replicate the current findings in larger, multi-
site, randomized controlled trials, with the inclusion of a well-matched, active control 
group. It is hoped that this study prompts much-needed further research that may aim 
to replicate these findings and more thoroughly investigate the effectiveness of 
cognitive training in SUD populations with comorbid conditions such as psychiatric 
diagnoses and history of head injury. 
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 Rates of cognitive recovery across the first year of SUD treatment have been 
investigated at group and individual levels, with qualitatively different trajectories of 
change observed between individuals (Bates et al., 2013b). This has implications for 
the development and implementation of neuropsychological interventions in SUD 
treatment contexts. As this area of research grows, studies could begin to explore the 
effectiveness of interventions for SUD across varying subgroups, in order to ascertain 
the influence of individual differences that are present in the often heterogeneous 
makeup of SUD populations, and tailor interventions accordingly. Studies that also 
track clinical outcomes related to sustained remission from SUDs (e.g., quality of life, 
length of stay in treatment, program completion, dropout, relapse to substance use) 
will be beneficial in further informing neuropsychological interventions as a strategy 
to reduce the individual and collective harms associated with SUDs. Nevertheless, the 
preliminary evidence from the current study suggests that CR may improve EFs, self-
regulation, and quality of life, and with further examination may be a promising 
intervention for use within residential SUD treatment settings.
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